-5%
Rivadem 4.5 Capsule is used in adult patients to manage:
- mild to moderately severe Alzheimer’s dementia
- mild to moderately severe dementia with Parkinson’s disease
Rivastigmine, a carbamate derivative structurally related to physostigmine, works by reversibly inhibiting acetylcholinesterase and butyrylcholinesterase, enzymes that degrade acetylcholine. This action increases acetylcholine levels at synapses, enhancing cholinergic transmission in the brain. Rivastigmine shows greater selectivity for central (brain) cholinesterase over peripheral forms, improving cognitive symptoms associated with dementia.
